Nuacres GmbH
- Biotech or pharma, therapeutic R&D
NuAcRes – a novel immunotherapy paradigm for solid tumors
Nucleic Acids to the Rescue GmbH ("NuAcRes") is a late- stage drug development company committed to driving a paradigm shift in the immunotherapeutic treatment of solid tumors. With our novel treatment algorithm ALTINADISUR, we can unleash the full power of the human immune system against solid tumors. Informed by deep analysis of immunotherapy outcomes in clinical trials, our algorithm alternates different immunotherapeutic treatments, including checkpoint inhibitors, to avoid immune exhaustion and treatment resistance, thereby enabling long-term tumor control.
ALTINADISUR can expand and prolong the efficacy of checkpoint inhibitors, together with our novel innate immune activator, offering renewed hope to the vast majority of unresponsive cancer patients today.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}